- Home
- TREE vs CMPX Comparison
TREE vs CMPX Comparison
Compare TREE & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- CMPX
- Stock Information
- Founded
- TREE 1996
- CMPX 2014
- Country
- TREE United States
- CMPX United States
- Employees
- TREE N/A
- CMPX N/A
- Industry
- TREE Finance: Consumer Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- TREE Finance
- CMPX Health Care
- Exchange
- TREE Nasdaq
- CMPX Nasdaq
- Market Cap
- TREE 711.4M
- CMPX 752.4M
- IPO Year
- TREE N/A
- CMPX N/A
- Fundamental
- Price
- TREE $50.82
- CMPX $4.91
- Analyst Decision
- TREE Strong Buy
- CMPX Strong Buy
- Analyst Count
- TREE 6
- CMPX 7
- Target Price
- TREE $72.50
- CMPX $14.43
- AVG Volume (30 Days)
- TREE 310.0K
- CMPX 1.9M
- Earning Date
- TREE 10-30-2025
- CMPX 11-05-2025
- Dividend Yield
- TREE N/A
- CMPX N/A
- EPS Growth
- TREE N/A
- CMPX N/A
- EPS
- TREE 1.04
- CMPX N/A
- Revenue
- TREE $1,059,158,000.00
- CMPX N/A
- Revenue This Year
- TREE $22.19
- CMPX N/A
- Revenue Next Year
- TREE $7.55
- CMPX N/A
- P/E Ratio
- TREE $48.81
- CMPX N/A
- Revenue Growth
- TREE 37.01
- CMPX N/A
- 52 Week Low
- TREE $33.50
- CMPX $1.33
- 52 Week High
- TREE $77.35
- CMPX $5.11
- Technical
- Relative Strength Index (RSI)
- TREE 39.22
- CMPX 67.40
- Support Level
- TREE $47.70
- CMPX $4.79
- Resistance Level
- TREE $51.72
- CMPX $5.11
- Average True Range (ATR)
- TREE 2.99
- CMPX 0.32
- MACD
- TREE -0.36
- CMPX 0.05
- Stochastic Oscillator
- TREE 17.66
- CMPX 86.34
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.